CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Cash flows from operating activities
Net Income
94,181
94,181
75,410
129,122
8,140
Depreciation & amortization
2,171
2,171
236
106
87
Deferred income taxes
16,877
16,877
14,067
-76,703
-
Stock based compensation
29,313
29,313
23,747
13,361
7,058
Change in working capital
-4,687
-4,687
3,926
-5,714
1,156
Accounts receivable
-2,340
-2,340
-2,288
-5,440
-3,639
Inventory
-1,044
-1,044
-7,779
-2,262
-682
Accounts Payable
-735
-735
-389
6,289
965
Other working capital
135,029
135,029
115,367
60,516
18,197
Other non-cash items
-1,738
-1,738
-1,721
470
1,950
Net cash provided by operating activites
136,117
136,117
115,665
60,935
18,391
Cash flows from investing activities
Investments in property, plant and equipment
-1,088
-1,088
-298
-419
-194
Purchases of investments
-299,035
-299,035
-233,124
-73,037
-
Sales/Maturities of investments
182,295
182,295
142,655
-
-
Net cash used for investing activites
-117,828
-117,828
-90,767
-73,456
-194
Cash flows from financing activities
Debt repayment
0
0
0
-15,134
-14,779
Common stock repurchased
-30,975
-30,975
-23,657
-
-
Other financing activites
-
-
-
-
-14,779
Net cash used privided by (used for) financing activities
-28,645
-28,645
-14,335
-7,953
-7,096
Net change in cash
-10,356
-10,356
10,563
-20,474
11,101
Cash at beginning of period
41,625
41,625
31,062
51,536
40,435
Cash at end of period
31,269
31,269
41,625
31,062
51,536
Free Cash Flow
Operating Cash Flow
136,117
136,117
115,665
60,935
18,391
Capital Expenditure
-1,088
-1,088
-298
-419
-194
Free Cash Flow
135,029
135,029
115,367
60,516
18,197